Bladder Cancer: Current Challenges and Future Directions
Bladder cancer (BCa) is the most common malignancy of the urinary tract and one of the most prevalent cancers worldwide. While the clinical approach to BCa has remained largely unchanged for many years, recent discoveries have paved the way to a new era of diagnosis and management of the disease. BC...
Main Authors: | Jakub Dobruch, Maciej Oszczudłowski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/57/8/749 |
Similar Items
-
The value of perioperative mitomycin C instillation in improving subsequent bacillus calmette-guerin instillation efficacy in intermediate and high-risk patients with non-muscle invasıve bladder cancer: a prospective randomized study
by: Ömer Gülpinar, et al.
Published: (2012-08-01) -
BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer
by: Sarah Lidagoster, et al.
Published: (2024-02-01) -
Perioperative Systemic Treatment for Muscle-Invasive Bladder Cancer: Current Evidence and Future Perspectives
by: In-Ho Kim, et al.
Published: (2021-07-01) -
BCG in Bladder Cancer Immunotherapy
by: Song Jiang, et al.
Published: (2022-06-01) -
Re-examination of the Natural History of High-grade T1 Bladder Cancer using a Large Contemporary Cohort
by: Daniel J. Canter, et al.
Published: (2014-04-01)